Pennsylvania Judge Denies Post-Trial Motions In $70M Risperdal Gynecomastia Trial

(July 27, 2016, 12:16 PM EDT) -- PHILADELPHIA — Twenty-five days after a jury awarded $70 million to a plaintiff in a Risperdal gynecomastia trial, a Pennsylvania state court judge on July 25 denied post-trial motions by both the plaintiff and defendants Janssen Pharmaceuticals Inc. and Johnson & Johnson (A.Y. v. Janssen Pharmaceuticals, No. 130402094, Pa. Comm. Pls., Philadelphia Co.)....

Related Sections